KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,195,438 | +7.6% | 68,822 | -12.7% | 0.00% | +100.0% |
Q2 2023 | $1,110,560 | -18.4% | 78,875 | -37.7% | 0.00% | -50.0% |
Q1 2023 | $1,361,635 | +159.7% | 126,546 | +261.6% | 0.00% | +100.0% |
Q4 2022 | $524,285 | -99.6% | 34,999 | +224.3% | 0.00% | – |
Q3 2022 | $138,569,000 | -15.6% | 10,792 | -36.3% | 0.00% | – |
Q2 2022 | $164,149,000 | -73.0% | 16,940 | -72.3% | 0.00% | -100.0% |
Q1 2022 | $608,298,000 | -9.2% | 61,197 | +7.5% | 0.00% | 0.0% |
Q4 2021 | $669,807,000 | +944.0% | 56,908 | +910.3% | 0.00% | – |
Q3 2021 | $64,160,000 | +328.8% | 5,633 | +424.5% | 0.00% | – |
Q2 2021 | $14,961,000 | -76.9% | 1,074 | -69.3% | 0.00% | – |
Q1 2021 | $64,766,000 | +18.8% | 3,499 | +13.4% | 0.00% | – |
Q4 2020 | $54,512,000 | -44.3% | 3,085 | -51.7% | 0.00% | – |
Q3 2020 | $97,895,000 | +177.0% | 6,390 | +360.7% | 0.00% | – |
Q2 2020 | $35,341,000 | -49.6% | 1,387 | -69.4% | 0.00% | – |
Q1 2020 | $70,062,000 | +182.5% | 4,526 | +101.9% | 0.00% | – |
Q4 2019 | $24,797,000 | +31.5% | 2,242 | +1.2% | 0.00% | – |
Q3 2019 | $18,858,000 | -9.4% | 2,216 | +44.2% | 0.00% | – |
Q2 2019 | $20,811,000 | -57.1% | 1,537 | -42.8% | 0.00% | – |
Q1 2019 | $48,491,000 | +691.8% | 2,685 | +1131.7% | 0.00% | – |
Q4 2018 | $6,124,000 | +74.0% | 218 | +58.0% | 0.00% | – |
Q3 2018 | $3,519,000 | – | 138 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |